Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Postdoctoral Fellow (Epigenetics Liquid Biopsy Markers) - CSIRO, Sydney, Australia

    Postdoctoral Fellowship on a project seeking to find and characterise circulating cell-free DNA biomarkers of traumatic brain injury.
    • Based at CSIRO, Sydney, NSW, Australia
    • AU $78k to $88k plus up to 15.4% superannuation
    • 3 year term.
    • Translational focus


    Essential Criteria:
    1. Demonstrated knowledge and understanding of molecular biology.
    2. Demonstrated knowledge and experience in bioinformatics for the analysis and interpretation of multi-dimensional datasets.
    3. Demonstrated proficiency in at least one data analysis language: R, Python, MATLAB.
    4. Willingness to work across regionally dispersed, multi-disciplinary research teams and institutions across Sydney and Brisbane and the motivation and discipline to carry out autonomous research.
    5. A record of science innovation and creativity, plus the ability and willingness to incorporate novel ideas and approaches into scientific investigations.


    Desirable Criteria:
    1. Knowledge of epigenetics.
    2. Experience in undertaking lab procedures with bisulfite-treated DNA. E.g. Methylation-specific PCR, bisulfite amplicon library preparation.
    3. Experience with Unix shell or a scripting, interpreted or compiled language: Python, Ruby, Perl, C++, Java, Scala.
    4. A knowledge of commonly used genomics tools for working with deep sequencing data.


    The Postdoctoral Fellow appointed to this role will join CSIRO’s Probing Biosystems team to undertake a Future Science Platform (FSP) project led by Dr Jason Ross. This project seeks to find and characterise circulating cell-free DNA biomarkers of traumatic brain injury with the translational goal of developing a clinical biomarker in this space. The Epigenetics Team in North Ryde, NSW has a long history in DNA methylation biomarker development, including the co-development of Colvera™ with the Clinical Genomics company. Colvera™ is a biomarker product for diagnosing and monitoring the recurrence of colorectal cancer.

    Postdoctoral Fellowships at CSIRO provide opportunities to scientists and engineers, who have completed their doctorate and have less than three years relevant postdoctoral work experience. These fellowships will help launch their careers, provide experience that will enhance their career prospects, and facilitate the recruitment and development of potential leaders for CSIRO.

    Applications close: 31 Jan 2017

    For more information and to apply, please download this position description document.
    Last edited by sci_guy; 01-02-2017, 05:25 PM. Reason: To update the PD link

  • #2
    Updated details

    The advertisement is on the CSIRO Vacancies Hub.

    I've updated the position description document link above here. The updated PD contains a corrected position reference number. Please apply for job reference: 31121.

    The PD is also available via the above advertisement.

    PM me if you would like more info.

    Regards,
    Jason
    Last edited by sci_guy; 01-02-2017, 05:26 PM.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Essential Discoveries and Tools in Epitranscriptomics
      by seqadmin


      The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist on Modified Bases...
      Yesterday, 07:01 AM
    • seqadmin
      Current Approaches to Protein Sequencing
      by seqadmin


      Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
      04-04-2024, 04:25 PM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 04-11-2024, 12:08 PM
    0 responses
    44 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 10:19 PM
    0 responses
    43 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 09:21 AM
    0 responses
    38 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-04-2024, 09:00 AM
    0 responses
    55 views
    0 likes
    Last Post seqadmin  
    Working...
    X